Matches in Nanopublications for { ?s ?p "[All selected markers except DSG3 were present at high levels in the primary tumors and at very low or non-detectable levels in normal LNs and PB in the first round of validation, indicating a potential for detecting tumor cells in NSCLC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP230414.RAX1xcJZw56L9lYyFmZO-DG7IlgfREWI_27nF-r9O3XrU130_assertion description "[All selected markers except DSG3 were present at high levels in the primary tumors and at very low or non-detectable levels in normal LNs and PB in the first round of validation, indicating a potential for detecting tumor cells in NSCLC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230414.RAX1xcJZw56L9lYyFmZO-DG7IlgfREWI_27nF-r9O3XrU130_provenance.
- NP537890.RAG9Logf2cP_CwWRN3vc_--HESozDSVMxv_oiy08tA08w130_assertion description "[All selected markers except DSG3 were present at high levels in the primary tumors and at very low or non-detectable levels in normal LNs and PB in the first round of validation, indicating a potential for detecting tumor cells in NSCLC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537890.RAG9Logf2cP_CwWRN3vc_--HESozDSVMxv_oiy08tA08w130_provenance.
- NP361672.RAAFyZMxcBozbMTxWM4OSUuFb8NH1a8qoNvPHkGpiZD9c130_assertion description "[All selected markers except DSG3 were present at high levels in the primary tumors and at very low or non-detectable levels in normal LNs and PB in the first round of validation, indicating a potential for detecting tumor cells in NSCLC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP361672.RAAFyZMxcBozbMTxWM4OSUuFb8NH1a8qoNvPHkGpiZD9c130_provenance.
- NP1077500.RAAYj4oplg7aDn2oS5wo1GJozUcflYk482gQ1WytenTck130_assertion description "[All selected markers except DSG3 were present at high levels in the primary tumors and at very low or non-detectable levels in normal LNs and PB in the first round of validation, indicating a potential for detecting tumor cells in NSCLC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1077500.RAAYj4oplg7aDn2oS5wo1GJozUcflYk482gQ1WytenTck130_provenance.
- assertion description "[All selected markers except DSG3 were present at high levels in the primary tumors and at very low or non-detectable levels in normal LNs and PB in the first round of validation, indicating a potential for detecting tumor cells in NSCLC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.